55 CAMBRIDGE PARKWAY, CAMBRIDGE, MA
To Acquire Pharmaceuticals, Expanding its Global Rare Disease Portfolio
Financial Results, Press Release
Investor Presentation
Provides Operational Update and Reports Third Quarter Financial Results
Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer
Announces Appointment of Bethany L. Sensenig to Board of Directors
Material Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sales of Equity Securities, Other Events
Provides Operational Update and Reports Fiscal Quarter Financial Results
Q3
Annual Report Transition
Q1
FY 2025
Q2
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Correspondence
Submission Upload